Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
2000 1
2001 1
2008 1
2013 1
2014 1
2019 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Overexpression of kif11 is a poor prognostic factor in clear cell renal cell carcinoma.
Kowalewski A, Jaworski D, Antosik P, Smolińska M, Ligmanowska J, Grzanka D, Szylberg Ł. Kowalewski A, et al. Pol J Pathol. 2022;73(2):82-87. doi: 10.5114/pjp.2022.118137. Pol J Pathol. 2022. PMID: 35979754 Free article.
We explored the relationship between KIF11 protein expression and the clinical courses of clear cell renal cell carcinoma (ccRCC) using a tissue microarray. ...KIF11 nuclear expression did not correlate with overall survival. CONCLUSIONS: Elevated expression of KIF11 pr …
We explored the relationship between KIF11 protein expression and the clinical courses of clear cell renal cell carcinoma (ccRCC) usi …
Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME, Shah SN, Elson P, Garcia JA, Wood LS, Medsinge A, Campbell S, Dreicer R, Rini BI. Salem ME, et al. Clin Genitourin Cancer. 2014 Apr;12(2):117-23. doi: 10.1016/j.clgc.2013.08.001. Epub 2013 Oct 12. Clin Genitourin Cancer. 2014. PMID: 24126239
Higher attenuation using computed tomography (CT) scans and favorable response according to Morphology, Attenuation, Size, and Structure (MASS) criteria after 2 cycles of sunitinib were independent predictors of subsequent tumor resection. INTRODUCTION: In patients with lo …
Higher attenuation using computed tomography (CT) scans and favorable response according to Morphology, Attenuation, Size, and Structure (MA …
A prospective, open-label, interventional study protocol to evaluate treatment efficacy of nivolumab based on serum-soluble PD-L1 concentration for patients with metastatic and unresectable renal cell carcinoma.
Bando Y, Hinata N, Omori T, Fujisawa M. Bando Y, et al. BMJ Open. 2019 Dec 10;9(12):e030522. doi: 10.1136/bmjopen-2019-030522. BMJ Open. 2019. PMID: 31826889 Free PMC article.
INTRODUCTION: Nivolumab has been proven to prolong overall survival as a second-line therapy for patients with advanced renal cell carcinoma (RCC) in a phase III clinical trial. However, versatile biomarkers have not been established to predict the efficacy of nivolumab ag …
INTRODUCTION: Nivolumab has been proven to prolong overall survival as a second-line therapy for patients with advanced renal cell carcinoma …
Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT, Su CT, Hu M, Taylor JMG, Daignault-Newton S, Kellezi O, Dahl MN, Shah MA, Erickson S, Lora J, Hamasha R, Ali A, Yancey S, Kiros L, Balicki HM, Winfield DC, Green MD, Alva AS. Ma VT, et al. Urol Oncol. 2021 Jul;39(7):437.e1-437.e9. doi: 10.1016/j.urolonc.2021.01.006. Epub 2021 Jan 23. Urol Oncol. 2021. PMID: 33495117 Free PMC article.
CONCLUSION: Greater frequency and higher grades of irAEs are associated with better treatment response in patients with RCC and urothelial malignancy receiving ICI therapy. The presence of liver metastases denotes a negative predictive marker for immunotherapy efficacy. SU …
CONCLUSION: Greater frequency and higher grades of irAEs are associated with better treatment response in patients with RCC and urothelial m …
Prognostic evaluation of transcatheter arterial embolization for unresectable renal cell carcinoma with distant metastasis.
Onishi T, Oishi Y, Suzuki Y, Asano K. Onishi T, et al. BJU Int. 2001 Mar;87(4):312-5. doi: 10.1046/j.1464-410x.2001.00070.x. BJU Int. 2001. PMID: 11251521
The two groups were compared for several clinical factors, mainly focusing on the prognosis. RESULTS: There were no significant differences in the clinical factors, including performance status, tumour diameter, vascular invasion, lymph node involvement, adjuvant therapy, …
The two groups were compared for several clinical factors, mainly focusing on the prognosis. RESULTS: There were no significant diffe …
Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-alpha, and tegafur-uracil: a single-institution experience.
Kobayashi M, Ikeda H, Nukui A, Suzuki K, Sugaya Y, Yuzawa M, Morita T. Kobayashi M, et al. Int J Clin Oncol. 2008 Jun;13(3):257-62. doi: 10.1007/s10147-007-0752-0. Epub 2008 Jun 14. Int J Clin Oncol. 2008. PMID: 18553237
BACKGROUND: The objective of the current study was to determine the efficacy and safety of very low-dose interleukin-2 (IL-2), interferon (IFN)-alpha, and tegafur-uracil for patients with unresectable renal cell carcinoma (RCC), metastatic RCC, or both. Clinical prognostic …
BACKGROUND: The objective of the current study was to determine the efficacy and safety of very low-dose interleukin-2 (IL-2), interferon (I …